The CAF-secreted urokinase-type plasminogen activator (uPA) binds to its receptor (uPAR), activating the integrin and epidermal growth factor receptor (EGFR) pathways and resulting in the subsequent activation of ERK and reduction of p38 activity, which promotes tumor cell proliferation [78]. The gene discussed is EGFR; the disease is neoplasm.